- BioPharm International-05-01-2003
- Volume 16
- Issue 5
Demonstrating the Consistency of Small Data Sets: Application of the Weisberg t-test for Outliers
by Robert J. Seely, Amgen, Inc. Louis Munyakazi, John Haury, Heather Simmerman, W. Heath Rushing, and Thomas F. Curry Determining whether a data point is an "outlier" ? a result that doesn't fit, that is too high or too low, that is extreme or discordant ? is difficult when using small data sets (such as the data from three, four, or five conformance runs). The authors show that the Weisberg t-test is a powerful tool for detecting deviations in small data sets.
Articles in this issue
over 22 years ago
Sumeria to Satellites: Evolution of the Bioreactorover 22 years ago
Patent Law: Extracting Maximum Value from Your Patent Portfolioover 22 years ago
Inside Washington: Medication Safety in the Limelightover 22 years ago
Part 11 Is Not Going Away: The New Electronic Records Draft Guidanceover 22 years ago
Survival Strategies: The Life Sciences Industry Turns to eLearningNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.